ArticleEMBO molecular medicine2022

THEM6-mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer.

Arnaud Blomme et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.